[Porphyrin excretion in patients with chronic hepatitis C virus infection]. 1997

R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
Department de Medicina Occidente, Hospital San Juan de Dios, Universidad de Chile, Santiago.

BACKGROUND The high prevalence of chronic hepatitis C virus infection in patients with porphyria cutanea tarda, specially in those without family history of the disease, suggests that this could be an acquired disease and one of the most frequent extra hepatic manifestations of hepatitis C virus infection. OBJECTIVE To study the excretion of porphyrins and its precursors in cirrhotic patients with and without hepatitis C virus infection. METHODS Eighteen patients with cirrhosis Child-Pough A, eight infected with hepatitis C virus, were studied. Urinary excretion of [symbol see text] aminolevulinic acid, porphobilinogen, coproporphyrins, uroporphyrins and fecal excretion of coproporphyrins and protoporphyrins were measured. Red blood cell protoporphyrin was also measured. RESULTS There were no differences in the measured parameters between patients with or without hepatitis C virus infection. No patient had uroporphyrin excretion values over the normal range. Some patients had slight elevations in some parameters, but always below the values observed in porphyrias. CONCLUSIONS In these group of patients, hepatitis C virus infection of its associated liver disease, do not cause detectable alterations in porphyrin metabolism.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017119 Porphyria Cutanea Tarda An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C

Related Publications

R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
August 1999, Clinical chemistry and laboratory medicine,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
January 2002, Journal of gastroenterology,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
February 1999, The Journal of rheumatology,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
January 2017, Mediterranean journal of hematology and infectious diseases,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
November 1995, Journal of hepatology,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
December 2018, Minerva gastroenterologica e dietologica,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
October 2016, The Journal of infectious diseases,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
October 2015, Immunology,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
July 2005, Current opinion in rheumatology,
R Armas-Merino, and C Wolff, and A Parraguez, and J R Soto
May 1998, Free radical biology & medicine,
Copied contents to your clipboard!